| human | Q5 |
| P496 | ORCID iD | 0000-0003-2770-0691 |
| P108 | employer | Mayo Clinic | Q1130172 |
| P735 | given name | Jonathan | Q1158394 |
| Jonathan | Q1158394 | ||
| P106 | occupation | researcher | Q1650915 |
| Q41650341 | 18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies |
| Q55245159 | 18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus. |
| Q96609427 | 18F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies |
| Q51393935 | A neurological complication of a uterine fibroid. |
| Q37670219 | A robust biomarker of large-scale network failure in Alzheimer's disease |
| Q37633577 | AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies |
| Q47653348 | Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. |
| Q90060454 | Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging |
| Q60309357 | Amyloid- and tau-PET imaging in a familial prion kindred |
| Q100315920 | Amyloid-β and tau biomarkers and clinical phenotype in dementia with Lewy bodies |
| Q41635671 | Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies |
| Q48572369 | An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease |
| Q102054980 | Artificial Intelligence-Electrocardiography to Predict Incident Atrial Fibrillation: A Population-Based Study |
| Q92496869 | Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint |
| Q47801025 | Association Between Microinfarcts and Blood Pressure Trajectories |
| Q90901643 | Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults |
| Q100731406 | Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment |
| Q91605447 | Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia |
| Q98905195 | Associations Between Plasma Ceramides and Cerebral Microbleeds or Lacunes |
| Q92843396 | Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia |
| Q100509978 | Associations of Quantitative Susceptibility Mapping with Alzheimer's Disease Clinical and Imaging Markers |
| Q36827384 | Atrial fibrillation, cognitive impairment, and neuroimaging |
| Q114888847 | Author Response: Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease |
| Q93376009 | Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods |
| Q92583591 | Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers |
| Q92994104 | CSF1R mutation presenting as dementia with Lewy bodies |
| Q90065965 | Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging |
| Q36722181 | Cascading network failure across the Alzheimer's disease spectrum |
| Q50085296 | Caudate nucleus as a component of networks controlling behavior |
| Q38609701 | Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation |
| Q40134938 | Cerebral amyloid angiopathy and implications for atrial fibrillation management |
| Q91697217 | Cerebral microbleed incidence, relationship to amyloid burden: The Mayo Clinic Study of Aging |
| Q90646389 | Cerebral microbleeds: Prevalence and relationship to amyloid burden |
| Q91259072 | Cerebrospinal fluid dynamics disorders: Relationship to Alzheimer biomarkers and cognition |
| Q34633026 | Clinical and radiologic correlations of central pontine myelinolysis syndrome |
| Q91557166 | Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration |
| Q55194533 | Clinicopathological and 123I-FP-CIT SPECT correlations in patients with dementia. |
| Q57060141 | Cognitive dysfunction in atrial fibrillation |
| Q91684761 | Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum |
| Q91023578 | Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin |
| Q38750711 | Consensus classification of posterior cortical atrophy |
| Q92418069 | Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults |
| Q114949978 | Deep learning identifies brain structures that predict cognition and explain heterogeneity in cognitive aging |
| Q114945773 | Deep learning-based brain age prediction in normal aging and dementia |
| Q34135742 | Dementia with Lewy bodies: basis of cingulate island sign |
| Q91838928 | Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging |
| Q37593611 | Dopamine agonists and Othello’s syndrome |
| Q39004053 | Duration and Pathologic Correlates of Lewy Body Disease |
| Q48518676 | Efficacy of Warfarin Anticoagulation and Incident Dementia in a Community-Based Cohort of Atrial Fibrillation |
| Q90065399 | Elevated Plasma Ceramides Are Associated With Higher White Matter Hyperintensity Volume-Brief Report |
| Q91546700 | Entorhinal cortex tau, amyloid-β, cortical thickness and memory performance in non-demented subjects |
| Q51052076 | Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals. |
| Q90523396 | Exposure to surgery under general anaesthesia and brain magnetic resonance imaging changes in older adults |
| Q47590759 | Extramedullary tumors and leukemia: a diagnostic pitfall for the neurologist |
| Q64267337 | F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy |
| Q88053895 | FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis |
| Q36117353 | Fluorodeoxyglucose F18 PET in progressive emotional dysprosody |
| Q49084827 | Fluorodeoxyglucose F18 positron emission tomography in a case of slowly progressive pure alexia |
| Q41990757 | Focal brain atrophy in gastric bypass patients with cognitive complaints |
| Q36011353 | Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer's disease |
| Q50050594 | Frequency of Acute and Subacute Infarcts in a Population-Based Study |
| Q91967302 | Frontal lobe 1H MR spectroscopy in asymptomatic and symptomatic MAPT mutation carriers |
| Q92496783 | Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases |
| Q37634324 | Globular Glial Tauopathy Presenting as Semantic Variant Primary Progressive Aphasia |
| Q48053020 | History of Hollenhorst plaques |
| Q36124416 | Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies |
| Q53396875 | Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease. |
| Q50026038 | In vivo 18F-AV-1451 tau-PET signal in MAPT mutation carriers varies by expected tau isoforms |
| Q91023531 | Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging |
| Q91619667 | Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration |
| Q41655722 | LRRK2 variation and dementia with Lewy bodies |
| Q104067076 | Lewy body disease is a contributor to logopenic progressive aphasia phenotype |
| Q36287837 | Limb immobilization and corticobasal syndrome |
| Q91360661 | Linear vs volume measures of ventricle size: Relation to present and future gait and cognition |
| Q100315921 | Longitudinal anatomic, functional and molecular characterization of Pick's disease phenotypes |
| Q96824373 | Longitudinal clinical, neuropsychological, and neuroimaging characterization of a kindred with a 12-octapeptide repeat insertion in PRNP: the next generation |
| Q96641958 | Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes |
| Q51763159 | Longitudinal tau PET in ageing and Alzheimer's disease. |
| Q64060660 | Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease |
| Q91953658 | MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous |
| Q30630699 | Magnetic resonance spectroscopy in Alzheimer's disease |
| Q88249456 | Microinfarcts and blood pressure trajectories: response to Dr Niu et al |
| Q104756263 | Mild Cognitive Impairment at Risk for Lewy Body Dementia |
| Q99552743 | Network localization of alien limb in patients with corticobasal syndrome |
| Q48025023 | Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities). |
| Q37415801 | Neuroimaging and clinical features in type II (late-onset) Alexander disease |
| Q45195179 | Pallidonigroluysian atrophy associated with p.A152T variant in MAPT. |
| Q42285850 | Parkinsonian motor features distinguish the agrammatic from logopenic variant of primary progressive aphasia |
| Q38164888 | Pathophysiology of language, speech and emotions in neurodegenerative disease |
| Q34715043 | Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies |
| Q95644330 | Pick's disease: clinicopathologic characterization of 21 cases |
| Q93047436 | Population-Based Evaluation of Lumbar Puncture Opening Pressures |
| Q38792674 | Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging |
| Q113178216 | Posterior cortical atrophy phenotypic heterogeneity revealed by decoding 18F-FDG-PET |
| Q37062727 | Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry |
| Q100949634 | Predicting future rates of tau accumulation on PET |
| Q40283154 | Preeclampsia and cognitive impairment later in life |
| Q96131509 | Prevalence and Heterogeneity of Cerebrovascular Disease Imaging Lesions |
| Q47602999 | Prevalence and Natural History of Superficial Siderosis: A Population-Based Study |
| Q91882184 | Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework |
| Q37522997 | Primary progressive aphasia and transient global amnesia |
| Q114888854 | Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease |
| Q97529257 | Progressive dysexecutive syndrome due to Alzheimer's disease: a description of 55 cases and comparison to other phenotypes |
| Q48639407 | Progressive multifocal leukoencephalopathy in a patient treated with etanercept |
| Q97536778 | Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort |
| Q51615537 | RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies. |
| Q92463670 | Rates of lobar atrophy in asymptomatic MAPT mutation carriers |
| Q100457884 | Reduced fractional anisotropy of the genu of the corpus callosum as a cerebrovascular disease marker and predictor of longitudinal cognition in MCI |
| Q55709566 | Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET. |
| Q37652823 | Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies |
| Q93051096 | Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging |
| Q49990629 | Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly |
| Q38198507 | Spinal cord injury from fluoroscopically guided intercostal blocks with phenol |
| Q91160627 | Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults |
| Q50008505 | Structured handoff checklists improve clinical measures in patients discharged from the neurointensive care unit |
| Q96609126 | Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution |
| Q40201095 | Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study |
| Q89476365 | TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease |
| Q37098471 | TREM2 p.R47H substitution is not associated with dementia with Lewy bodies |
| Q47987344 | Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum |
| Q50042853 | Tau-negative amnestic dementia masquerading as Alzheimer disease dementia |
| Q47854896 | The Heart-Brain Team-Towards an Optimal Team-Based Coordinated Care |
| Q37557624 | The alien limb phenomenon |
| Q90006715 | The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes |
| Q35841143 | The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation |
| Q39130723 | The effects of statin therapy on carotid plaque composition and volume: A systematic review and meta-analysis |
| Q91010566 | The influence of β-amyloid on [18F]AV-1451 in semantic variant of primary progressive aphasia |
| Q47666324 | The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies |
| Q90855799 | The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology |
| Q92239415 | The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies |
| Q37731903 | The neuroanatomy of pure apraxia of speech in stroke |
| Q53008683 | The right arm likes to be close. |
| Q90485727 | Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers |
| Q92524786 | Trajectory of lobar atrophy in asymptomatic and symptomatic GRN mutation carriers: a longitudinal MRI study |
| Q48395067 | Transient amnesia after coiling of a posterior circulation aneurysm |
| Q50193680 | Uptake of AV-1451 in meningiomas |
| Q92496790 | Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium |
| Q35168935 | Valproate-induced Fanconi syndrome in a 27-year-old woman |
| Q35019559 | Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study |
| Q47655041 | Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers |
| Q92748372 | White matter hyperintensities: relationship to amyloid and tau burden |
| Q47330246 | Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia |
| Q48261458 | [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease |
| Q49937027 | [18F]AV-1451 tau-PET and primary progressive aphasia |
| Q92162097 | β-Amyloid PET and neuropathology in dementia with Lewy bodies |
Search more.